by Maria Zannes | Mar 24, 2023 | Publications
JoVE Journal, March 24, 2023 Authors William Bauta, Marcia Grayson, Rossella Titone, Jennifer Rebeles, Vivienne I. Rebel Abstract Flow cytometry can rapidly characterize and quantify diverse cell populations based on fluorescence measurements. The cells are first...
by Maria Zannes | Mar 23, 2023 | Press Releases
SAN ANTONIO, Texas (March 24, 2023) – bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced it will report financial results for the three months ended December 31, 2022, on Friday, March 31, 2023, after the market close. The Company will host a...
by Maria Zannes | Mar 6, 2023 | Articles, News
MARCH 6, 2023 The Empowered Patient podcast host Karen Jagoda recently interviewed bioAffinity Technologies President and CEO Maria Zannes about the development of the CyPath® Lung test for the detection of early-stage lung cancer. Hear the podcast at...
by Maria Zannes | Mar 6, 2023 | Events
MARCH 6, 2023 You’ve developed a great healthcare/life science idea, discovered a market for it and launched your business. Now what? The Health Cell’s monthly meeting Thursday, March 9, 2023, from 11:30 a.m. to 1 p.m. at the La Quinta Wyndham San Antonio Medical...
by Maria Zannes | Feb 22, 2023 | Articles, News
FEBRUARY 22, 2023 bioAffinity Technologies President and CEO Maria Zannes recently joined host Seth Farbman on his podcast From Start-Up to Stock Exchange. Listen here https://lnkd.in/g-vkTfKv to learn more about the need for early screening for lung cancer when it is...
